CD8A and neoplasm: COX2-derived PGE2 is a pleiotropic molecule that has been shown to act on many cell types including CD8+ T cells, DCs, and NK cells (47), although single-cell sequencing studies have revealed EP2 and EP4 receptors to be highly expressed specifically on tumor-infiltrating myeloid cells (48).